Scientific Program

Get a sneak peek below at some of the exciting plenary sessions that will be part of the IPVC 2023 scientific program.

More is coming soon!

If you want to be the first to know all IPVC 2023 updates, sign up for our newsletter here.

* Selected sessions in Kyoto will be provided with simultaneous translation to Japanese, please refer to the program for more information.

Program at a Glance

* Updated as of June 16, 2022
** Program remains subject to change.

To review the scientific program and the confirmed speakers, please click on the drop-down menu below:

Opening Ceremony and IPVC Plenary Session 1

Tuesday, March 28, 2023 | 16:00 – 17:30 | Hall A

Comparing and Contrasting COVID-19 Control With HPV Control and Elimination
Barney Graham (USA)

 

IPVC Plenary Session 2: HPV Vaccination

Wednesday, March 29, 2023 | 11:00 – 12:30 | Hall A

One-Dose HPV Vaccination Overview and a Focus on the KENSHE Data
Ruanne Barnabas (USA)
New Prophylactic HPV Vaccines
Richard Roden (USA)
Therapeutic Vaccines in Particular With Clinical Outcomes Such As CIN 3
Mayumi Nakagawa (USA)

 

IPVC Plenary Session 3: Lessons Learned From Other Disease Control Programs such as HIV, Hepatitis B and Anal Cancer Control Approaches

Thursday, March 30, 2023 | 08:30 – 10:00 | Hall A

Lessons Learned From Other Disease Control Programs such as HIV
Helen Rees (South Africa)
What Can We Learn From the Hepatitis B Model in Elimination of HPV Related Diseases?
Mark Kane (USA)
Anal Cancer Control Approaches
Joel Palefsky (USA)

 

IPVC Plenary Session 4: Carcinogenesis of Cutaneous Papillomaviruses for Non-melanoma Skin Cancer Molecular and Immunological Aspects

Thursday, March 30, 2023 | 15:15 – 16:45 | Hall A

Mastomys coucha: a unique animal model for papillomavirus-induced skin carcinogenesis
Frank Rösl (Germany)
Pros and Cons of Beta HPVs as Causative Agents in Skin Cancer
Denise Galloway (USA)
Epidemiology and Biology of Beta Human Papillomavirus Types
Massimo Tommasino (Italy)

 

IPVC Plenary Session 5: COVID 19 Effect on the WHO Elimination Plan for Cervical Cancer

Friday, March 31, 2023 | 11:00 – 12:30 | Hall A

COVID 19 Effect on Cervical Screening
Mona Saraiya (USA)
COVID 19 Effect on HPV Vaccination
Karen Canfell (Australia)
What and How Will It Take to Achieve Cervical Cancer Elimination Goal by 2030 With a Perspective for Low to Middle-Income Countries?
Yin Ling Woo (Malaysia)

 

Closing Ceremony and IPVC Plenary Session 6:

Friday, March 31, 2023 | 16:30 – 18:00 | Hall A

The Future Is Now
Douglas Lowy (USA)

Visit 2021 website Membership